Evidence map›Paper›PMID 39348194›Full record

ArticleRheumatology (Oxford, England)2025

Systemic inflammation in asymptomatic hyperuricaemia with sonographic crystal deposits, including a comparison with normouricaemia and gout.

María-Luisa Peral-Garrido, Silvia Gómez-Sabater, Rocío Caño, Alejandra Bermúdez-García, Paula Boix, Teresa Lozano, Ruth Sánchez-Ortiga, Miguel Perdiguero, Elena Caro-Martínez, Carolina Ruiz-García and 3 more

Abstract readComparative Study
In one paragraph

Article in Rheumatology (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

María-Luisa Peral-GarridoRheumatology Section, Vinalopó University Hospital, Elche, Spain.
Silvia Gómez-SabaterRheumatology Section, Dr. Balmis Alicante General University Hospital, Alicante, Spain.
Rocío CañoRheumatology Section, Dr. Balmis Alicante General University Hospital, Alicante, Spain.
Alejandra Bermúdez-GarcíaRheumatology Section, Dr. Balmis Alicante General University Hospital, Alicante, Spain.
Paula BoixClinical Medicine Department, Miguel Hernández University of Elche, Alicante, Spain.
Teresa LozanoResearch Group on Rheumatic and Autoimmune Diseases, Alicante Healthcare and Biomedical Research Institute (ISABIAL), Alicante, Spain.ORCID 0000-0003-4066-3573
Ruth Sánchez-OrtigaResearch Group on Rheumatic and Autoimmune Diseases, Alicante Healthcare and Biomedical Research Institute (ISABIAL), Alicante, Spain.
Miguel PerdigueroResearch Group on Rheumatic and Autoimmune Diseases, Alicante Healthcare and Biomedical Research Institute (ISABIAL), Alicante, Spain.
Elena Caro-MartínezInternal Medicine Service, Hospital Sant Vicent del Raspeig-HACLE, San Vicente del Raspeig, Spain.
Carolina Ruiz-GarcíaPrimary Care, Campoamor Health Center, Alicante, Spain.
Rubén FrancésClinical Medicine Department, Miguel Hernández University of Elche, Alicante, Spain.
Eliseo PascualClinical Medicine Department, Miguel Hernández University of Elche, Alicante, Spain.
Mariano AndrésClinical Medicine Department, Miguel Hernández University of Elche, Alicante, Spain.ORCID 0000-0002-0219-9055

Funding

Acción Estratégica en Salud 2021Alicante Healthcare and Biomedical Research InstituteCarlos III Health InstituteEuropean UnionGeneralitat ValencianaGrünenthal laboratoriesX Convocatoria de Ayudas para el Apoyo y Fomento de La Investigación del Instituto
6 · The paper itself

Abstract

objectiveTo describe the inflammatory profile of asymptomatic hyperuricaemia (AH) with ultrasound evidence of monosodium urate (MSU) crystals (AH-MSUpos), vs AH without deposits (AH-MSUneg), intercritical gout and normouricaemia.

methodsBased on serum urate levels, musculoskeletal ultrasound and history of flares, we divided 122 participants into four groups: normouricaemia, AH-MSUneg, AH-MSUpos and intercritical gout. We tested four ultrasound definitions for MSU deposition in AH: grade 2-3 (G2-3) double contour and/or tophi, G1-3 double contour and/or tophi, G1-3 Stewart scheme (double contour sign in knee cartilage and/or first metatarsophalangeal joint and/or tophi in first metatarsophalangeal joint) and G2-3 Stewart scheme. Serum acute phase reactants, cytokines, pyroptosis derivates and neutrophil-related proteins were measured and compared between groups. A linear regression model was fitted to correlate crystal and inflammatory burden (measured by ultrasound) with inflammatory markers in hyperuricaemics.

resultsRates of MSU deposition in AH ranged from 26.0% to 68.8%, depending on the definition used. Levels of CRP, leukocytes, IL-1RA, IL-6, sIL-6R, IL-18, TNF-α, TGF-β and galectin-3 were higher in hyperuricaemics vs normouricaemics. Sex, obesity and comorbidity scores influenced some comparisons. We saw no differences comparing AH-MSUposvs AH-MSUneg groups, except for higher calprotectin using G1-3 sonographic definitions and higher CRP and TGF-β when restricted to women and obese participants.

conclusionsHyperuricaemia is associated with substantial inflammation and some degree of active pyroptosis. Four different ultrasound definitions for AH with MSU deposits yielded similar findings, although we noted some differences in calprotectin, CRP, and TGF-β. Sex, obesity, and comorbidities influenced some inflammatory responses.

Indexed as

GoutHyperuricemiaInflammationUric AcidAdultAgedAsymptomatic DiseasesBiomarkersFemaleHumansMaleMetatarsophalangeal JointMiddle AgedUltrasonographyBiomarkersUric Acidacute phase reactantsasymptomatic hyperuricaemiacytokinesdepositsgoutinflammation

Identifiers

PMID39348194
PMCPMC11962879

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.